Study identification

PURI

https://redirect.ema.europa.eu/resource/18842

EU PAS number

EUPAS8044

Study ID

18842

Official title and acronym

Evaluation of the Effectiveness of Risk Minimisation Measures: A Joint PASS Survey among Health Care Professionals to Assess their Knowledge and Attitudes on Prescribing Conditions of Trimetazidine in Bulgaria, Czech Republic, Estonia, France, Hungary, Latvia, Lithuania, Poland, Portugal, Romania, Slovakia, and Spain

DARWIN EU® study

No

Study countries

Bulgaria
Czechia
Estonia
France
Hungary
Latvia
Lithuania
Poland
Portugal
Romania
Slovakia
Spain

Study description

Evaluation of the Effectiveness of Risk Minimisation Measures: A Joint PASS Survey among Health Care Professionals to Assess their Knowledge and Attitudes on Prescribing Conditions of Trimetazidine in Bulgaria, Czech Republic, Estonia, France, Hungary, Latvia, Lithuania, Poland, Portugal, Romania, Slovakia, and Spain

Study status

Finalised
Research institution and networks

Institutions

Contact details

Toussi Massoud

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Consortium led by Lupin
Study protocol
Initial protocol

Trimetazidine Lupin Survey Protocol_update 24 Nov 2014, V3.0, clean

English (1.09 MB - PDF)View document
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)